LIPOPROTEINS DURING ORAL AND CUTANEOUS ADMINISTRATION OF OESTRADIOL-17-BETA TO MENOPAUSAL WOMEN

被引：52

作者：

FAHRAEUS, L ^{[1
]}

LARSSONCOHN, U ^{[1
]}

WALLENTIN, L ^{[1
]}

机构：

[1] LINKOPING UNIV HOSP,DEPT INTERNAL MED,S-58185 LINKOPING,SWEDEN

来源：

ACTA ENDOCRINOLOGICA | 1982年 / 101卷 / 04期

关键词：

D O I：

10.1530/acta.0.1010597

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：597 / 602

页数：6

相关论文

共 25 条

[21] HDL3 AND HDL2 DETERMINATION BY A COMBINED ULTRA-CENTRIFUGATION AND PRECIPITATION PROCEDURE
WALLENTIN, L
FAHRAEUS, L
[J]. CLINICA CHIMICA ACTA, 1981, 116 (02) : 199 - 208
[22] METABOLIC AND HORMONAL EFFECTS OF POSTMENOPAUSAL ESTROGEN REPLACEMENT TREATMENT .2. PLASMA-LIPIDS
WALLENTIN, L
LARSSONCOHN, U
[J]. ACTA ENDOCRINOLOGICA, 1977, 86 (03): : 597 - 607
[23] WHITEHEAD MI, 1980, PERCUTANEOUS ABSORPT, P231
[24] CIRCULATING ESTRADIOL, ESTRONE AND GONADOTROPIN LEVELS FOLLOWING ADMINISTRATION OF ORALLY ACTIVE 17 BETA-ESTRADIOL IN POSTMENOPAUSAL WOMEN
YEN, SSC
MARTIN, PL
BURNIER, AM
CZEKALA, NM
GREANEY, MO
CALLANTINE, MR
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 40 (03) : 518 - 521
[25] 1975, NIH DHEW75628 PUBL, V1